scholarly journals Mid-septal accessory pathway in a young professional athlete: when and how to ablate?

2020 ◽  
Vol 30 (1) ◽  
pp. 62-66
Author(s):  
Ioan-Alexandru Minciuna ◽  
Mihai Puiu ◽  
Gelu Simu ◽  
Gabriel Cismaru ◽  
Radu Rosu ◽  
...  
Keyword(s):  
Catheter Ablation ◽  
Accessory Pathway ◽  
Atrioventricular Node ◽  
Complete Atrioventricular Block ◽  
Professional Athlete ◽  
Wpw Syndrome ◽  
European Guidelines ◽  
Young Professional ◽  
Increased Risk ◽  
Complete Atrioventricular

Wolf-Parkinson-White (WPW) syndrome is responsible for 1% of all deaths in athletes. Considering the increased risk of sudden cardiac death (SCD) in athletes compared to general population, a comprehensive risk stratification is crucial. Both American and European guidelines recommend electrophysiology (EP) study for risk assessment and catheter ablation as the fi rst-line treatment in athletes with WPW syndrome. Radiofrequency (RF) catheter ablation is the routine treatment for most accessory pathways (AP). However, cryo-energy ablation is recommended for APs located close to the atrioventricular node, in particular mid-septal and superoparaseptal, because of the increased risk of complete atrioventricular block with RF ablation. Depending on the European or American guidelines, athletes should be granted clearance for competitive sports 1 month after the procedure if free of symptoms and without pre-excitation recurrence on ECG.

scholarly journals Radiofrequency Catheter Ablation of Parahisian Accessory Pathway

2016 ◽  
Vol 1 (1) ◽  
pp. 92-96
Author(s):  
Szilamér Korodi ◽  
István Kovács ◽  
Edvin Benedek ◽  
András Mester ◽  
Laura Jani ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
High Risk ◽  
Catheter Ablation ◽  
Low Power ◽  
Atrioventricular Block ◽  
Radiofrequency Catheter Ablation ◽  
Accessory Pathway ◽  
Complete Atrioventricular Block ◽  
Radiofrequency Current ◽  
Complete Atrioventricular

Abstract Radiofrequency catheter ablation of parahisian accessory pathways in pre-excitation syndrome is a challenging task, due to the extremely high risk of complete atrioventricular block. In this brief report we describe the case of a 32 year-old man presenting a parahisian accessory pathway, who has been successfully treated by radiofrequency ablation. Radiofrequency catheter ablation using low-power radiofrequency current is considered to be the most appropiate method of ablation in adult patients.

scholarly journals Successful Prevention of Fetal Autoimmune-Mediated Heart Block by Combined Therapies With Hydroxychloroquine and Intravenous Immunoglobulin: A Case Report

2021 ◽  
Vol 8 ◽  
Author(s):  
Li Zhao ◽  
Yan Zhou ◽  
Chuan Wang ◽  
Yifei Li ◽  
Qi Zhu ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Atrioventricular Block ◽  
Heart Block ◽  
Immunoglobulin A ◽  
Atrioventricular Node ◽  
Complete Atrioventricular Block ◽  
Life Threatening ◽  
Short Time ◽  
Successful Prevention ◽  
Complete Atrioventricular

A fetal autoimmune-mediated atrioventricular block is a passively acquired autoimmune disease in which maternal autoantibodies enter the fetal circulation via the placenta and subsequently cause inflammation and fibrosis of the atrioventricular node. Once fetal autoimmune-mediated atrioventricular block occurs, it only takes a short time to progress from first-degree atrioventricular block to complete atrioventricular block, meaning that the damage is often irreversible. Autoimmune—associated AVB, a rare but life—threatening disorder, occurs in 2–5% of pregnancies with positive anti—Ro/SSA (the most common one) and La/SSB antibodies. The perinatal mortality of neonates with AVB outlined in research is approximately 30%. Thus far, for autoimmune-associated AVB fetuses, currently used treatments include corticosteroids, hydroxychloroquine, intravenous immunoglobulin (IVIG), b—sympathomimetic agent, and even plasma exchange. Currently, approaches for preventing the progression and recurrence of a fetal atrioventricular block are still controversial. Here, we reported a baby of successful prevention from the fate of the fetal atrioventricular block by adopting prophylactic comprehensive prenatal therapy.

scholarly journals Wolff-Parkinson-White (WPW) Syndrome Catheter Ablation in Prince Sultan Cardiac Center

2021 ◽  
Vol 4 (14) ◽  
pp. 01-06
Author(s):  
Ibrahim Yaseen M Osman ◽  
Yahya Alhebaishi ◽  
Lamia Alshengeiti ◽  
Khalid Dagriri ◽  
Adil Asman ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Young Adult ◽  
Catheter Ablation ◽  
Supraventricular Tachycardia ◽  
Accessory Pathway ◽  
Wpw Syndrome ◽  
Common Causes ◽  
Cardiac Center

Despite being one of the most common causes of supraventricular tachycardia in young adult, there are not many studies that highlight the demographics data as well as procedural characteristics of accessory pathway in Saudi Arabia.

Pacing therapy in children with isolated complete atrioventricular block: a retrospective study of pacing system survival and pacing-related complications in a national cohort

EP Europace ◽  
2019 ◽  
Vol 21 (11) ◽  
pp. 1717-1724 ◽  
Author(s):  
Håkan Eliasson ◽  
Sven-Erik Sonesson ◽  
Stina Salomonsson ◽  
Amanda Skog Andreasson ◽  
Marie Wahren-Herlenius ◽  
...  
Keyword(s):  
Risk Factor ◽  
Retrospective Study ◽  
Atrioventricular Block ◽  
Young Patients ◽  
Complete Atrioventricular Block ◽  
Increased Risk ◽  
National Cohort ◽  
Epicardial Pacing ◽  
Complete Atrioventricular ◽  
Pacing Leads

Abstract Aims To evaluate pacing system survival and complications to pacemaker (PM) therapy in children with isolated complete atrioventricular block (CAVB). Methods and results We performed a nationwide retrospective study of children diagnosed before 15 years of age with isolated CAVB and PM treatment. Between 1983 and 2012, 127 patients underwent PM-implantations at 3.2 (0–17) [median (range)] years and were followed for 11 (0.6–19) years. An endocardial or epicardial PM system was implanted in 72 and 55 patients, respectively. A total of 306 pacing leads (76% steroid-eluting) were implanted. Pacing system survival was significantly affected by age, with a higher risk of a new intervention for children aged <1 month at first implantation. Lead survival of the steroid-eluting leads at 5 and 10 years was 90 and 81%, respectively, with no difference between epicardial and endocardial systems. Complications leading to revision of the pacing system occurred in 24% of the patients. Patients aged <1 month at first PM implantation had a five-fold increased risk for a complication to occur. Dividing the cohort according to year of first procedure showed that those who had their first implantation ≥2002 had fewer complications and also lead- and pacing system survival was better in the later cohort. Conclusion Pacing system survival and complications to PM therapy in young patients with isolated CAVB were significantly affected by age, with low age at PM implantation constituting a risk factor. Endocardial and epicardial pacing systems showed no significant differences in performance.

Sign in / Sign up

Export Citation Format

Share Document